<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02497027</url>
  </required_header>
  <id_info>
    <org_study_id>AIHG-1440-PGxUPA</org_study_id>
    <nct_id>NCT02497027</nct_id>
  </id_info>
  <brief_title>Pharmacogenetic Testing in an Outpatient Population of Patients With Depression</brief_title>
  <acronym>PGx-UPA</acronym>
  <official_title>Pharmacogenetic Testing in an Outpatient Population of Patients With Major Depressive Disorder or Depressive Disorder Not Otherwise Specified</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Avera McKennan Hospital &amp; University Health Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Avera McKennan Hospital &amp; University Health Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, control group design of pharmacogenetic implementation in a mental
      health population of subjects taking anti-depressants and/or anti-psychotics with a new or
      current primary or secondary diagnosis of Major Depressive Disorder (MDD) or Depressive
      Disorder Not Otherwise Specified (DDNOS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, control group design of pharmacogenetic implementation in a mental
      health population of subjects taking anti-depressants and/or anti-psychotics with a new or
      current primary or secondary diagnosis of Major Depressive Disorder (MDD) or Depressive
      Disorder Not Otherwise Specified (DDNOS). Prospective data will be collected on all subjects
      until study completion at 24-25 weeks post enrollment. Claims data may be reviewed per pay,
      if such data are readily available in a timely manner.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">April 1, 2017</completion_date>
  <primary_completion_date type="Actual">April 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Depression score</measure>
    <time_frame>24 weeks</time_frame>
    <description>response to medication following medication recommendation guided by pharmacogenetic testing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical utility questionnaire</measure>
    <time_frame>24 weeks</time_frame>
    <description>This will be assessed through review of medical records and a study compliance questionnaire to be completed by the prescribing physician</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">83</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>4-Week Group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Pharmacogenetic testing released to physician at 4 weeks following enrollment into study</description>
  </arm_group>
  <arm_group>
    <arm_group_label>12-Week Group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Pharmacogenetic testing released to physician at 12 weeks following enrollment into study</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>pharmacogenetic testing</intervention_name>
    <description>pharmacogenetic testing report released to physician at 4 weeks post enrollment</description>
    <arm_group_label>4-Week Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>pharmacogenetic testing</intervention_name>
    <description>pharmacogenetic testing report released to physician at 12 weeks post enrollment</description>
    <arm_group_label>12-Week Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Current primary or secondary diagnosis of Major Depressive Disorder or Depressive
             Disorder Not Otherwise Specified

          -  Have moderate to severe depression as identified by PHQ-9 scoring of 10 or greater

          -  Taking or be newly prescribed an anti-depressant or anti-psychotic medication

          -  Able to provide informed consent

          -  Prescribing physician practices at the Avera Medical Group University Psychiatry
             Associates clinic in Sioux Falls, SD

        Exclusion Criteria:

          -  Pregnant or breastfeeding

          -  Active and/or unstable diagnosis of substance abuse, excluding nicotine

          -  Primary diagnosis of dementia, bipolar disorder (any type), schizophrenia,
             schizoaffective disorder, or personality disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew Stanley, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Avera McKennan Hospital &amp; University Health Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Avera McKennan Hospital &amp; University Health Center</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 15, 2015</study_first_submitted>
  <study_first_submitted_qc>July 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2015</study_first_posted>
  <last_update_submitted>May 2, 2017</last_update_submitted>
  <last_update_submitted_qc>May 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pharmacogenetic, pharmacogenomic, depressive, mental health</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

